| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.20e-09 | 303 | 38 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 5.57e-08 | 187 | 38 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 6.69e-08 | 562 | 38 | 10 | GO:0003712 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 4.38e-07 | 33 | 38 | 4 | GO:0050681 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 BCL9L NCOA3 KMT2C NCOA6 MAML2 UBQLN2 SS18 RBM33 CNOT2 EP300 SS18L1 | 9.23e-07 | 1160 | 38 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 3.05e-06 | 53 | 38 | 4 | GO:0030331 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 BCL9L NCOA3 KMT2C NCOA6 MAML2 UBQLN2 SS18 RBM33 CNOT2 EP300 SS18L1 | 4.73e-06 | 1356 | 38 | 12 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 5.38e-06 | 61 | 38 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 7.09e-06 | 20 | 38 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 8.26e-06 | 21 | 38 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription factor binding | 8.96e-06 | 753 | 38 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.19e-05 | 417 | 38 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 3.65e-05 | 34 | 38 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 9.91e-05 | 582 | 38 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.42e-04 | 140 | 38 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 3.33e-04 | 320 | 38 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 3.63e-04 | 326 | 38 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 8.70e-04 | 23 | 38 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.36e-03 | 1459 | 38 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 1.69e-03 | 32 | 38 | 2 | GO:0140142 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.03e-03 | 1244 | 38 | 8 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 2.32e-03 | 1271 | 38 | 8 | GO:0000987 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 4.24e-03 | 51 | 38 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 4.91e-03 | 55 | 38 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.91e-03 | 55 | 38 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 5.64e-03 | 59 | 38 | 2 | GO:0031593 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 5.82e-03 | 60 | 38 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.00e-03 | 206 | 38 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 7.01e-03 | 66 | 38 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 7.01e-03 | 66 | 38 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | histone modifying activity | 9.35e-03 | 229 | 38 | 3 | GO:0140993 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 9.67e-03 | 78 | 38 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.17e-02 | 86 | 38 | 2 | GO:0046332 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 9.90e-09 | 87 | 37 | 6 | GO:0033143 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.45e-07 | 136 | 37 | 6 | GO:0030518 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.13e-07 | 155 | 37 | 6 | GO:0043401 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.48e-06 | 202 | 37 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | negative regulation of lung goblet cell differentiation | 3.13e-06 | 2 | 37 | 2 | GO:1901250 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 BCL9L NCOA3 KMT2C FOXP1 NCOA6 BMPR2 MAML2 SS18 EP300 SS18L1 SMAD5 | 3.19e-06 | 1390 | 37 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 3.91e-06 | 239 | 37 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 4.41e-06 | 244 | 37 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of lung goblet cell differentiation | 9.38e-06 | 3 | 37 | 2 | GO:1901249 | |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 9.38e-06 | 3 | 37 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.05e-05 | 24 | 37 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | embryo development | NCOA3 FOXP1 NCOA6 FOXP4 BMPR2 LATS1 FOXP2 DYNC2H1 CNOT2 EP300 SMAD5 | 2.85e-05 | 1437 | 37 | 11 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 3.64e-05 | 36 | 37 | 3 | GO:0033146 | |
| GeneOntologyBiologicalProcess | lung goblet cell differentiation | 4.68e-05 | 6 | 37 | 2 | GO:0060480 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 5.47e-05 | 381 | 37 | 6 | GO:0048545 | |
| GeneOntologyBiologicalProcess | lobar bronchus epithelium development | 6.54e-05 | 7 | 37 | 2 | GO:0060481 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrogen peroxide-mediated programmed cell death | 6.54e-05 | 7 | 37 | 2 | GO:1901300 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 8.64e-05 | 605 | 37 | 7 | GO:0071407 | |
| GeneOntologyBiologicalProcess | lobar bronchus development | 8.71e-05 | 8 | 37 | 2 | GO:0060482 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 8.89e-05 | 416 | 37 | 6 | GO:0030522 | |
| GeneOntologyBiologicalProcess | lung development | 1.13e-04 | 269 | 37 | 5 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 1.21e-04 | 273 | 37 | 5 | GO:0030323 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 1.45e-04 | 57 | 37 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 1.78e-04 | 61 | 37 | 3 | GO:0060428 | |
| GeneOntologyBiologicalProcess | head development | 1.84e-04 | 919 | 37 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | respiratory system development | 2.02e-04 | 305 | 37 | 5 | GO:0060541 | |
| GeneOntologyBiologicalProcess | bronchus development | 2.41e-04 | 13 | 37 | 2 | GO:0060433 | |
| GeneOntologyBiologicalProcess | lung secretory cell differentiation | 3.24e-04 | 15 | 37 | 2 | GO:0061140 | |
| GeneOntologyBiologicalProcess | heart development | 3.43e-04 | 757 | 37 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 3.68e-04 | 78 | 37 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 4.35e-04 | 558 | 37 | 6 | GO:0060537 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 4.61e-04 | 1053 | 37 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 4.70e-04 | 18 | 37 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | regulation of hydrogen peroxide-mediated programmed cell death | 5.25e-04 | 19 | 37 | 2 | GO:1901298 | |
| GeneOntologyBiologicalProcess | endocytosis | 5.84e-04 | 827 | 37 | 7 | GO:0006897 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 6.64e-04 | 223 | 37 | 4 | GO:0007519 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide-mediated programmed cell death | 7.07e-04 | 22 | 37 | 2 | GO:0010421 | |
| GeneOntologyBiologicalProcess | striatum development | 7.07e-04 | 22 | 37 | 2 | GO:0021756 | |
| GeneOntologyBiologicalProcess | brain development | 7.31e-04 | 859 | 37 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 8.33e-04 | 237 | 37 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | programmed cell death in response to reactive oxygen species | 8.43e-04 | 24 | 37 | 2 | GO:0097468 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 8.73e-04 | 240 | 37 | 4 | GO:0060538 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 9.01e-04 | 242 | 37 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.03e-03 | 911 | 37 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.06e-03 | 1194 | 37 | 8 | GO:0000902 | |
| GeneOntologyBiologicalProcess | organ growth | 1.11e-03 | 256 | 37 | 4 | GO:0035265 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.13e-03 | 445 | 37 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | subpallium development | 1.15e-03 | 28 | 37 | 2 | GO:0021544 | |
| GeneOntologyBiologicalProcess | smooth muscle tissue development | 1.23e-03 | 29 | 37 | 2 | GO:0048745 | |
| GeneOntologyBiologicalProcess | growth | 1.31e-03 | 1235 | 37 | 8 | GO:0040007 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 1.41e-03 | 31 | 37 | 2 | GO:0060765 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.46e-03 | 276 | 37 | 4 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.61e-03 | 482 | 37 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.72e-03 | 727 | 37 | 6 | GO:0032870 | |
| GeneOntologyCellularComponent | transcription regulator complex | 8.65e-05 | 596 | 38 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.28e-04 | 1377 | 38 | 10 | GO:0140513 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.10e-04 | 12 | 38 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | chromatin | 2.32e-04 | 1480 | 38 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.45e-03 | 31 | 38 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.46e-03 | 272 | 38 | 4 | GO:0090575 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 2.17e-03 | 38 | 38 | 2 | GO:0030125 | |
| MousePheno | abnormal myocardium compact layer morphology | 1.20e-05 | 67 | 30 | 4 | MP:0004056 | |
| MousePheno | prenatal lethality, incomplete penetrance | 1.75e-05 | 747 | 30 | 9 | MP:0011101 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 2.01e-05 | 410 | 30 | 7 | MP:0031660 | |
| MousePheno | embryonic lethality, incomplete penetrance | 2.01e-05 | 410 | 30 | 7 | MP:0011102 | |
| MousePheno | abnormal heart development | 1.18e-04 | 372 | 30 | 6 | MP:0000267 | |
| MousePheno | thin myocardium compact layer | 1.27e-04 | 46 | 30 | 3 | MP:0004057 | |
| Domain | FOXP-CC | 3.10e-08 | 4 | 38 | 3 | PF16159 | |
| Domain | FOXP-CC | 3.10e-08 | 4 | 38 | 3 | IPR032354 | |
| Domain | Nuc_rcpt_coact | 1.55e-07 | 6 | 38 | 3 | IPR009110 | |
| Domain | DUF4927 | 4.03e-06 | 2 | 38 | 2 | PF16279 | |
| Domain | DUF4927 | 4.03e-06 | 2 | 38 | 2 | IPR032565 | |
| Domain | DUF1518 | 1.21e-05 | 3 | 38 | 2 | PF07469 | |
| Domain | DUF1518 | 1.21e-05 | 3 | 38 | 2 | IPR010011 | |
| Domain | Src1_rcpt_coact | 1.21e-05 | 3 | 38 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 1.21e-05 | 3 | 38 | 2 | IPR017426 | |
| Domain | SSXT | 1.21e-05 | 3 | 38 | 2 | PF05030 | |
| Domain | DUF1518 | 1.21e-05 | 3 | 38 | 2 | SM01151 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 1.21e-05 | 3 | 38 | 2 | IPR014920 | |
| Domain | SS18_fam | 1.21e-05 | 3 | 38 | 2 | IPR007726 | |
| Domain | SRC-1 | 1.21e-05 | 3 | 38 | 2 | IPR014935 | |
| Domain | SRC-1 | 1.21e-05 | 3 | 38 | 2 | PF08832 | |
| Domain | - | 1.21e-05 | 3 | 38 | 2 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 1.21e-05 | 3 | 38 | 2 | PF08815 | |
| Domain | UBA | 5.30e-05 | 36 | 38 | 3 | PF00627 | |
| Domain | Ubiquilin | 6.02e-05 | 6 | 38 | 2 | IPR015496 | |
| Domain | UBA | 9.71e-05 | 44 | 38 | 3 | IPR015940 | |
| Domain | TF_fork_head_CS_2 | 1.11e-04 | 46 | 38 | 3 | IPR030456 | |
| Domain | UBA | 1.18e-04 | 47 | 38 | 3 | PS50030 | |
| Domain | TF_fork_head_CS_1 | 1.18e-04 | 47 | 38 | 3 | IPR018122 | |
| Domain | FORK_HEAD_3 | 1.34e-04 | 49 | 38 | 3 | PS50039 | |
| Domain | FH | 1.34e-04 | 49 | 38 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.34e-04 | 49 | 38 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.34e-04 | 49 | 38 | 3 | PS00658 | |
| Domain | Forkhead | 1.34e-04 | 49 | 38 | 3 | PF00250 | |
| Domain | Fork_head_dom | 1.34e-04 | 49 | 38 | 3 | IPR001766 | |
| Domain | STI1_HS-bd | 1.80e-04 | 10 | 38 | 2 | IPR006636 | |
| Domain | STI1 | 1.80e-04 | 10 | 38 | 2 | SM00727 | |
| Domain | UBA-like | 2.97e-04 | 64 | 38 | 3 | IPR009060 | |
| Domain | IMPORTIN_B_NT | 3.61e-04 | 14 | 38 | 2 | PS50166 | |
| Domain | IBN_N | 4.16e-04 | 15 | 38 | 2 | PF03810 | |
| Domain | IBN_N | 4.75e-04 | 16 | 38 | 2 | SM00913 | |
| Domain | Importin-beta_N | 5.38e-04 | 17 | 38 | 2 | IPR001494 | |
| Domain | ZF_ZZ_2 | 6.04e-04 | 18 | 38 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 6.04e-04 | 18 | 38 | 2 | PS01357 | |
| Domain | ZZ | 6.04e-04 | 18 | 38 | 2 | PF00569 | |
| Domain | Znf_ZZ | 6.74e-04 | 19 | 38 | 2 | IPR000433 | |
| Domain | 6-PGluconate_DH_C-like | 6.74e-04 | 19 | 38 | 2 | IPR008927 | |
| Domain | ZnF_ZZ | 6.74e-04 | 19 | 38 | 2 | SM00291 | |
| Domain | PAS | 1.17e-03 | 25 | 38 | 2 | PF00989 | |
| Domain | PAS_fold | 1.17e-03 | 25 | 38 | 2 | IPR013767 | |
| Domain | UBA | 1.69e-03 | 30 | 38 | 2 | SM00165 | |
| Domain | PAS | 1.92e-03 | 32 | 38 | 2 | SM00091 | |
| Domain | PAS | 2.17e-03 | 34 | 38 | 2 | IPR000014 | |
| Domain | PAS | 2.17e-03 | 34 | 38 | 2 | PS50112 | |
| Domain | UBIQUITIN_1 | 2.57e-03 | 37 | 38 | 2 | PS00299 | |
| Domain | UBQ | 3.45e-03 | 43 | 38 | 2 | SM00213 | |
| Domain | ubiquitin | 4.11e-03 | 47 | 38 | 2 | PF00240 | |
| Domain | ARM-type_fold | 4.84e-03 | 339 | 38 | 4 | IPR016024 | |
| Domain | UBIQUITIN_2 | 5.40e-03 | 54 | 38 | 2 | PS50053 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 5.61e-06 | 18 | 28 | 3 | M26942 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.15e-05 | 84 | 28 | 4 | M1008 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.75e-05 | 30 | 28 | 3 | M207 | |
| Pathway | REACTOME_ADIPOGENESIS | 6.22e-05 | 110 | 28 | 4 | M48259 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 7.94e-05 | 7 | 28 | 2 | M47845 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 8.18e-05 | 118 | 28 | 4 | M27316 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 9.31e-05 | 122 | 28 | 4 | M29689 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.22e-04 | 49 | 28 | 3 | M41832 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.28e-04 | 254 | 28 | 5 | M27131 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 1.36e-04 | 9 | 28 | 2 | M47822 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.70e-04 | 10 | 28 | 2 | MM15535 | |
| Pathway | PID_ALK2_PATHWAY | 2.07e-04 | 11 | 28 | 2 | M203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 2.07e-04 | 11 | 28 | 2 | M47848 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 2.07e-04 | 11 | 28 | 2 | M47503 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.48e-04 | 12 | 28 | 2 | M27159 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.67e-04 | 1432 | 28 | 10 | M509 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 2.70e-04 | 64 | 28 | 3 | M200 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.82e-04 | 65 | 28 | 3 | M39682 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.41e-04 | 14 | 28 | 2 | M27808 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 3.51e-04 | 70 | 28 | 3 | M938 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 3.93e-04 | 15 | 28 | 2 | M119 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 4.49e-04 | 16 | 28 | 2 | M27121 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 5.71e-04 | 18 | 28 | 2 | MM14775 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 6.43e-04 | 86 | 28 | 3 | M2642 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.07e-04 | 20 | 28 | 2 | M27881 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 7.07e-04 | 20 | 28 | 2 | M47843 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 7.58e-04 | 91 | 28 | 3 | M39700 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 8.57e-04 | 22 | 28 | 2 | MM1370 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.11e-03 | 25 | 28 | 2 | M27880 | |
| Pathway | PID_ALK1_PATHWAY | 1.20e-03 | 26 | 28 | 2 | M185 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.20e-03 | 26 | 28 | 2 | MM14793 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.29e-03 | 27 | 28 | 2 | M26943 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.49e-03 | 29 | 28 | 2 | M48076 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.71e-03 | 31 | 28 | 2 | M39476 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 1.71e-03 | 31 | 28 | 2 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 1.71e-03 | 31 | 28 | 2 | MM14789 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 1.82e-03 | 32 | 28 | 2 | M39567 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.93e-03 | 33 | 28 | 2 | M604 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 2.43e-03 | 37 | 28 | 2 | M17400 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.69e-03 | 39 | 28 | 2 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.12e-03 | 42 | 28 | 2 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 3.12e-03 | 42 | 28 | 2 | M17541 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 3.12e-03 | 42 | 28 | 2 | M48018 | |
| Pathway | PID_BMP_PATHWAY | 3.12e-03 | 42 | 28 | 2 | M181 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 3.12e-03 | 42 | 28 | 2 | M27172 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.12e-03 | 149 | 28 | 3 | M27888 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 3.24e-03 | 314 | 28 | 4 | M39428 | |
| Pathway | PID_HNF3A_PATHWAY | 3.42e-03 | 44 | 28 | 2 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.42e-03 | 44 | 28 | 2 | M27295 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.88e-03 | 161 | 28 | 3 | M27871 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.89e-03 | 47 | 28 | 2 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 4.06e-03 | 48 | 28 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.06e-03 | 48 | 28 | 2 | M611 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 4.22e-03 | 49 | 28 | 2 | M27614 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.22e-03 | 49 | 28 | 2 | M618 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 4.39e-03 | 50 | 28 | 2 | MM15817 | |
| Pathway | PID_AR_TF_PATHWAY | 4.92e-03 | 53 | 28 | 2 | M151 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 4.92e-03 | 53 | 28 | 2 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 5.29e-03 | 55 | 28 | 2 | M39351 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 5.29e-03 | 55 | 28 | 2 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 5.29e-03 | 55 | 28 | 2 | M27001 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 5.87e-03 | 58 | 28 | 2 | M29616 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 6.07e-03 | 59 | 28 | 2 | M39886 | |
| Pathway | PID_NOTCH_PATHWAY | 6.07e-03 | 59 | 28 | 2 | M17 | |
| Pathway | REACTOME_SUMOYLATION | 6.07e-03 | 189 | 28 | 3 | M27214 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 6.27e-03 | 60 | 28 | 2 | M41830 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 6.48e-03 | 61 | 28 | 2 | M39540 | |
| Pathway | PID_AR_PATHWAY | 6.48e-03 | 61 | 28 | 2 | M58 | |
| Pubmed | NCOA2 BCL9L NCOA3 KMT2C FOXP1 NCOA6 FOXP4 SCAF11 FOXP2 SS18 SMAP2 RBM33 CNOT2 EP300 SS18L1 SMAD5 | 5.74e-13 | 1429 | 38 | 16 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 BCL9L NCOA3 KMT2C FOXP1 NCOA6 FOXP4 FOXP2 EP300 SS18L1 | 3.55e-12 | 351 | 38 | 10 | 38297188 |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 14516685 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 1.20e-09 | 3 | 38 | 3 | 19907493 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 28507505 | ||
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 1.20e-09 | 3 | 38 | 3 | 25027557 | |
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 14701752 | ||
| Pubmed | Identification and characterization of T reg-like cells in zebrafish. | 4.81e-09 | 4 | 38 | 3 | 29066577 | |
| Pubmed | 5.79e-09 | 20 | 38 | 4 | 11877444 | ||
| Pubmed | 7.15e-09 | 21 | 38 | 4 | 19596656 | ||
| Pubmed | 1.20e-08 | 5 | 38 | 3 | 12714702 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 1.20e-08 | 5 | 38 | 3 | 9812974 | |
| Pubmed | 1.54e-08 | 268 | 38 | 7 | 33640491 | ||
| Pubmed | 2.40e-08 | 6 | 38 | 3 | 17619227 | ||
| Pubmed | 2.40e-08 | 6 | 38 | 3 | 28591638 | ||
| Pubmed | 2.40e-08 | 6 | 38 | 3 | 16923966 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.89e-08 | 457 | 38 | 8 | 32344865 | |
| Pubmed | 4.20e-08 | 7 | 38 | 3 | 20185820 | ||
| Pubmed | 4.20e-08 | 7 | 38 | 3 | 12709428 | ||
| Pubmed | 4.84e-08 | 33 | 38 | 4 | 18662545 | ||
| Pubmed | 6.71e-08 | 8 | 38 | 3 | 12082103 | ||
| Pubmed | 6.71e-08 | 8 | 38 | 3 | 14747462 | ||
| Pubmed | Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. | 6.71e-08 | 8 | 38 | 3 | 10504300 | |
| Pubmed | 6.71e-08 | 8 | 38 | 3 | 10490106 | ||
| Pubmed | 1.01e-07 | 9 | 38 | 3 | 11087842 | ||
| Pubmed | 1.18e-07 | 549 | 38 | 8 | 38280479 | ||
| Pubmed | Forkhead Box Protein P1 Is Dispensable for Retina but Essential for Lens Development. | 1.44e-07 | 10 | 38 | 3 | 28384713 | |
| Pubmed | Foxp1/2/4 regulate endochondral ossification as a suppresser complex. | 1.97e-07 | 11 | 38 | 3 | 25527076 | |
| Pubmed | 1.97e-07 | 11 | 38 | 3 | 36613751 | ||
| Pubmed | NCOA2 NCOA3 KMT2C FOXP1 NCOA6 NOP58 CLINT1 RBM33 EP300 IPO11 | 2.08e-07 | 1103 | 38 | 10 | 34189442 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.27e-07 | 398 | 38 | 7 | 35016035 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 KMT2C FOXP1 PTPN4 FOXP4 SCAF11 BMPR2 NLGN4Y DTNB EP300 XPO7 | 3.53e-07 | 1489 | 38 | 11 | 28611215 |
| Pubmed | 4.34e-07 | 14 | 38 | 3 | 12482968 | ||
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 4.34e-07 | 14 | 38 | 3 | 11500849 | |
| Pubmed | 4.59e-07 | 57 | 38 | 4 | 18022353 | ||
| Pubmed | 6.67e-07 | 16 | 38 | 3 | 23870121 | ||
| Pubmed | 6.67e-07 | 16 | 38 | 3 | 26021489 | ||
| Pubmed | 6.67e-07 | 16 | 38 | 3 | 22542185 | ||
| Pubmed | 7.82e-07 | 65 | 38 | 4 | 26655900 | ||
| Pubmed | 8.10e-07 | 17 | 38 | 3 | 19183483 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 30031127 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 1.16e-06 | 2 | 38 | 2 | 30104377 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 35759955 | ||
| Pubmed | Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. | 1.16e-06 | 2 | 38 | 2 | 21220509 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 30273195 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 11030627 | ||
| Pubmed | A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells. | 1.16e-06 | 2 | 38 | 2 | 30048685 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 24893771 | ||
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 1.16e-06 | 2 | 38 | 2 | 15056695 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 8758910 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 25853299 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27224915 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 11358962 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 28741757 | ||
| Pubmed | Compensation between FOXP transcription factors maintains proper striatal function. | 1.16e-06 | 2 | 38 | 2 | 38761373 | |
| Pubmed | Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci. | 1.16e-06 | 2 | 38 | 2 | 16484776 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 26040939 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 26647308 | ||
| Pubmed | Rnf165/Ark2C enhances BMP-Smad signaling to mediate motor axon extension. | 1.58e-06 | 21 | 38 | 3 | 23610558 | |
| Pubmed | Foxp1 Regulates Neural Stem Cell Self-Renewal and Bias Toward Deep Layer Cortical Fates. | 1.83e-06 | 22 | 38 | 3 | 32049024 | |
| Pubmed | 2.09e-06 | 83 | 38 | 4 | 28794006 | ||
| Pubmed | Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. | 2.72e-06 | 25 | 38 | 3 | 17428829 | |
| Pubmed | 3.07e-06 | 26 | 38 | 3 | 27341756 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 3.48e-06 | 3 | 38 | 2 | 14716005 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 21035760 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 21059860 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15145939 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 21735116 | ||
| Pubmed | Absence of the steroid receptor coactivator-3 induces B-cell lymphoma. | 3.48e-06 | 3 | 38 | 2 | 16675958 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15698540 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 9506940 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 28390937 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19277704 | ||
| Pubmed | Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences. | 3.48e-06 | 3 | 38 | 2 | 23927929 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19052561 | ||
| Pubmed | The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription. | 3.48e-06 | 3 | 38 | 2 | 12569362 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18372346 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 21330447 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 3.48e-06 | 3 | 38 | 2 | 11823864 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18845648 | ||
| Pubmed | The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. | 3.48e-06 | 3 | 38 | 2 | 12138202 | |
| Pubmed | AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. | 3.48e-06 | 3 | 38 | 2 | 10866661 | |
| Pubmed | Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. | 3.48e-06 | 3 | 38 | 2 | 12687690 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11923473 | ||
| Pubmed | Structure and chromosomal locations of mouse steroid receptor coactivator gene family. | 3.48e-06 | 3 | 38 | 2 | 10501088 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16926188 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11435705 | ||
| Pubmed | Foxp1 expression is essential for sex-specific murine neonatal ultrasonic vocalization. | 3.48e-06 | 3 | 38 | 2 | 28204507 | |
| Pubmed | The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. | 3.48e-06 | 3 | 38 | 2 | 16423883 | |
| Pubmed | 3.87e-06 | 28 | 38 | 3 | 29365100 | ||
| Pubmed | 3.87e-06 | 28 | 38 | 3 | 24880616 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 3.96e-06 | 877 | 38 | 8 | 20211142 | |
| Pubmed | 5.21e-06 | 638 | 38 | 7 | 31182584 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 26066330 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 16227615 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 33589584 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 28398509 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 18267973 | ||
| Pubmed | Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells. | 6.96e-06 | 4 | 38 | 2 | 15331759 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 10598588 | ||
| Interaction | EGR2 interactions | NCOA2 BCL9L NCOA3 KMT2C FOXP1 NCOA6 FOXP4 FOXP2 EP300 SS18L1 | 5.72e-13 | 171 | 38 | 10 | int:EGR2 |
| Interaction | SP7 interactions | NCOA2 BCL9L NCOA3 KMT2C FOXP1 NCOA6 FOXP4 SS18 RBM33 EP300 SS18L1 | 6.44e-12 | 304 | 38 | 11 | int:SP7 |
| Interaction | CRX interactions | NCOA2 BCL9L NCOA3 KMT2C FOXP1 FOXP4 FOXP2 SMAP2 EP300 SS18L1 | 2.94e-11 | 254 | 38 | 10 | int:CRX |
| Interaction | TBR1 interactions | 3.23e-11 | 113 | 38 | 8 | int:TBR1 | |
| Interaction | TBXT interactions | 3.99e-11 | 116 | 38 | 8 | int:TBXT | |
| Interaction | PAX9 interactions | 1.00e-10 | 130 | 38 | 8 | int:PAX9 | |
| Interaction | FEV interactions | 1.13e-10 | 203 | 38 | 9 | int:FEV | |
| Interaction | SOX7 interactions | 1.62e-10 | 82 | 38 | 7 | int:SOX7 | |
| Interaction | GSC interactions | 2.47e-10 | 87 | 38 | 7 | int:GSC | |
| Interaction | ERG interactions | 2.61e-10 | 223 | 38 | 9 | int:ERG | |
| Interaction | PAX8 interactions | 1.39e-09 | 111 | 38 | 7 | int:PAX8 | |
| Interaction | KLF5 interactions | 2.54e-09 | 195 | 38 | 8 | int:KLF5 | |
| Interaction | PAX7 interactions | 3.03e-09 | 124 | 38 | 7 | int:PAX7 | |
| Interaction | IRF4 interactions | 1.17e-08 | 85 | 38 | 6 | int:IRF4 | |
| Interaction | SOX17 interactions | 2.29e-08 | 95 | 38 | 6 | int:SOX17 | |
| Interaction | HNF4A interactions | 3.72e-08 | 275 | 38 | 8 | int:HNF4A | |
| Interaction | TLX3 interactions | 5.76e-08 | 291 | 38 | 8 | int:TLX3 | |
| Interaction | NR2F1 interactions | 7.73e-08 | 58 | 38 | 5 | int:NR2F1 | |
| Interaction | GCM1 interactions | 1.73e-07 | 68 | 38 | 5 | int:GCM1 | |
| Interaction | FOXI1 interactions | 7.92e-07 | 92 | 38 | 5 | int:FOXI1 | |
| Interaction | TLX1 interactions | 8.63e-07 | 175 | 38 | 6 | int:TLX1 | |
| Interaction | NUP35 interactions | 1.01e-06 | 424 | 38 | 8 | int:NUP35 | |
| Interaction | ALG13 interactions | 1.12e-06 | 183 | 38 | 6 | int:ALG13 | |
| Interaction | C1orf94 interactions | 1.39e-06 | 103 | 38 | 5 | int:C1orf94 | |
| Interaction | MYOD1 interactions | 1.57e-06 | 194 | 38 | 6 | int:MYOD1 | |
| Interaction | FOS interactions | 1.67e-06 | 312 | 38 | 7 | int:FOS | |
| Interaction | ASCL2 interactions | 1.75e-06 | 13 | 38 | 3 | int:ASCL2 | |
| Interaction | BNC2 interactions | 1.75e-06 | 13 | 38 | 3 | int:BNC2 | |
| Interaction | GATA2 interactions | 1.82e-06 | 199 | 38 | 6 | int:GATA2 | |
| Interaction | SMG7 interactions | 1.93e-06 | 319 | 38 | 7 | int:SMG7 | |
| Interaction | NR1I2 interactions | 1.97e-06 | 48 | 38 | 4 | int:NR1I2 | |
| Interaction | TOX interactions | 2.22e-06 | 14 | 38 | 3 | int:TOX | |
| Interaction | NR1H3 interactions | 4.24e-06 | 58 | 38 | 4 | int:NR1H3 | |
| Interaction | PAX6 interactions | 4.78e-06 | 366 | 38 | 7 | int:PAX6 | |
| Interaction | HIC2 interactions | 5.19e-06 | 61 | 38 | 4 | int:HIC2 | |
| Interaction | SOX15 interactions | 6.51e-06 | 141 | 38 | 5 | int:SOX15 | |
| Interaction | ELF5 interactions | 7.97e-06 | 147 | 38 | 5 | int:ELF5 | |
| Interaction | BMP6 interactions | 8.04e-06 | 21 | 38 | 3 | int:BMP6 | |
| Interaction | ETV4 interactions | 8.51e-06 | 69 | 38 | 4 | int:ETV4 | |
| Interaction | SOX6 interactions | 1.10e-05 | 157 | 38 | 5 | int:SOX6 | |
| Interaction | WWTR1 interactions | 1.21e-05 | 422 | 38 | 7 | int:WWTR1 | |
| Interaction | SOX5 interactions | 1.28e-05 | 162 | 38 | 5 | int:SOX5 | |
| Interaction | TLE6 interactions | 1.38e-05 | 25 | 38 | 3 | int:TLE6 | |
| Interaction | RXRA interactions | 1.57e-05 | 169 | 38 | 5 | int:RXRA | |
| Interaction | RFX1 interactions | 1.61e-05 | 81 | 38 | 4 | int:RFX1 | |
| Interaction | GGA2 interactions | 1.86e-05 | 84 | 38 | 4 | int:GGA2 | |
| Interaction | PAX2 interactions | 1.95e-05 | 85 | 38 | 4 | int:PAX2 | |
| Interaction | PPARG interactions | 2.18e-05 | 307 | 38 | 6 | int:PPARG | |
| Interaction | ETV1 interactions | 2.18e-05 | 29 | 38 | 3 | int:ETV1 | |
| Interaction | SS18 interactions | 2.24e-05 | 88 | 38 | 4 | int:SS18 | |
| Interaction | LHX2 interactions | 2.30e-05 | 183 | 38 | 5 | int:LHX2 | |
| Interaction | JUN interactions | 2.42e-05 | 470 | 38 | 7 | int:JUN | |
| Interaction | NFIA interactions | 2.62e-05 | 188 | 38 | 5 | int:NFIA | |
| Interaction | PPARA interactions | 2.67e-05 | 92 | 38 | 4 | int:PPARA | |
| Interaction | HNF1B interactions | 2.76e-05 | 190 | 38 | 5 | int:HNF1B | |
| Interaction | ZBTB39 interactions | 3.25e-05 | 33 | 38 | 3 | int:ZBTB39 | |
| Interaction | SOX9 interactions | 3.28e-05 | 97 | 38 | 4 | int:SOX9 | |
| Interaction | SOX13 interactions | 3.88e-05 | 35 | 38 | 3 | int:SOX13 | |
| Interaction | SOX2 interactions | NCOA2 BCL9L NCOA3 KMT2C FOXP1 NCOA6 FOXP4 NOP58 CLINT1 SS18 EP300 | 4.22e-05 | 1422 | 38 | 11 | int:SOX2 |
| Interaction | NFAT5 interactions | 4.99e-05 | 38 | 38 | 3 | int:NFAT5 | |
| Interaction | AGFG1 interactions | 5.38e-05 | 110 | 38 | 4 | int:AGFG1 | |
| Interaction | THRA interactions | 5.57e-05 | 111 | 38 | 4 | int:THRA | |
| Interaction | TFF1 interactions | 6.27e-05 | 41 | 38 | 3 | int:TFF1 | |
| Interaction | SATB1 interactions | 6.61e-05 | 116 | 38 | 4 | int:SATB1 | |
| Interaction | TSACC interactions | 7.23e-05 | 7 | 38 | 2 | int:TSACC | |
| Interaction | GDF6 interactions | 7.23e-05 | 7 | 38 | 2 | int:GDF6 | |
| Interaction | AR interactions | 7.32e-05 | 992 | 38 | 9 | int:AR | |
| Interaction | CEBPA interactions | NCOA2 NCOA3 KMT2C FOXP1 NCOA6 NOP58 CLINT1 RBM33 EP300 IPO11 | 7.51e-05 | 1245 | 38 | 10 | int:CEBPA |
| Interaction | SMAD2 interactions | 7.70e-05 | 385 | 38 | 6 | int:SMAD2 | |
| Interaction | GGA1 interactions | 7.79e-05 | 121 | 38 | 4 | int:GGA1 | |
| Interaction | RORC interactions | 8.31e-05 | 45 | 38 | 3 | int:RORC | |
| Interaction | EYA4 interactions | 8.87e-05 | 243 | 38 | 5 | int:EYA4 | |
| Interaction | MOAP1 interactions | 8.88e-05 | 46 | 38 | 3 | int:MOAP1 | |
| Interaction | VDR interactions | 9.40e-05 | 127 | 38 | 4 | int:VDR | |
| Interaction | CREBBP interactions | 1.12e-04 | 599 | 38 | 7 | int:CREBBP | |
| Interaction | MTNR1B interactions | 1.19e-04 | 135 | 38 | 4 | int:MTNR1B | |
| Interaction | PMEPA1 interactions | 1.21e-04 | 51 | 38 | 3 | int:PMEPA1 | |
| Interaction | EID1 interactions | 1.21e-04 | 51 | 38 | 3 | int:EID1 | |
| Interaction | DYNLL2 interactions | 1.29e-04 | 263 | 38 | 5 | int:DYNLL2 | |
| Interaction | NCOR2 interactions | 1.31e-04 | 264 | 38 | 5 | int:NCOR2 | |
| Interaction | NR2F2 interactions | 1.33e-04 | 139 | 38 | 4 | int:NR2F2 | |
| Interaction | TGFB1I1 interactions | 1.36e-04 | 53 | 38 | 3 | int:TGFB1I1 | |
| Interaction | NCOA2 interactions | 1.41e-04 | 141 | 38 | 4 | int:NCOA2 | |
| Interaction | MEF2C interactions | 1.44e-04 | 54 | 38 | 3 | int:MEF2C | |
| Interaction | NFIB interactions | 1.45e-04 | 142 | 38 | 4 | int:NFIB | |
| Interaction | FAM168A interactions | 1.45e-04 | 142 | 38 | 4 | int:FAM168A | |
| Interaction | ZNF148 interactions | 1.53e-04 | 144 | 38 | 4 | int:ZNF148 | |
| Interaction | AMY2B interactions | 1.54e-04 | 10 | 38 | 2 | int:AMY2B | |
| Interaction | NCOA6 interactions | 1.57e-04 | 145 | 38 | 4 | int:NCOA6 | |
| Interaction | AP1S2 interactions | 1.60e-04 | 56 | 38 | 3 | int:AP1S2 | |
| Interaction | NCOA1 interactions | 1.61e-04 | 146 | 38 | 4 | int:NCOA1 | |
| Interaction | YWHAH interactions | 1.63e-04 | 1102 | 38 | 9 | int:YWHAH | |
| Interaction | SMAD3 interactions | 1.74e-04 | 447 | 38 | 6 | int:SMAD3 | |
| Interaction | AP1G1 interactions | 1.79e-04 | 150 | 38 | 4 | int:AP1G1 | |
| Interaction | PLAAT3 interactions | 1.88e-04 | 11 | 38 | 2 | int:PLAAT3 | |
| Interaction | SMARCE1 interactions | 1.93e-04 | 287 | 38 | 5 | int:SMARCE1 | |
| Interaction | EP300 interactions | NCOA2 NCOA3 NCOA6 NOP58 CLINT1 MAML2 SS18 EP300 SS18L1 SMAD5 | 2.00e-04 | 1401 | 38 | 10 | int:EP300 |
| Interaction | KLF15 interactions | 2.03e-04 | 290 | 38 | 5 | int:KLF15 | |
| Interaction | CEBPD interactions | 2.17e-04 | 62 | 38 | 3 | int:CEBPD | |
| Interaction | FDCSP interactions | 2.26e-04 | 12 | 38 | 2 | int:FDCSP | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.77e-06 | 17 | 26 | 3 | 486 | |
| GeneFamily | Ubiquilin family | 1.98e-05 | 5 | 26 | 2 | 783 | |
| GeneFamily | Forkhead boxes | 3.14e-05 | 43 | 26 | 3 | 508 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.00e-04 | 18 | 26 | 2 | 91 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.85e-04 | 25 | 26 | 2 | 775 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.08e-02 | 110 | 26 | 2 | 420 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NCOA3 SYNRG KMT2C PTPN4 SCAF11 LATS1 SMAP2 RBM33 LYST CNOT2 EP300 | 5.66e-06 | 1492 | 38 | 11 | M40023 |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 3.86e-05 | 131 | 38 | 4 | M39232 | |
| Coexpression | AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS | 4.21e-05 | 134 | 38 | 4 | M39133 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 6.36e-05 | 294 | 38 | 5 | M40873 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 9.91e-05 | 323 | 38 | 5 | M9150 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_483_5P_GENES | 1.12e-04 | 11 | 38 | 2 | MM17503 | |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 1.32e-04 | 180 | 38 | 4 | M8906 | |
| Coexpression | GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN | 1.50e-04 | 186 | 38 | 4 | M7127 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 1.70e-04 | 192 | 38 | 4 | M2317 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 1.76e-04 | 194 | 38 | 4 | MM910 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 1.98e-04 | 200 | 38 | 4 | M9490 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN | 1.98e-04 | 200 | 38 | 4 | M9469 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_DN | 1.98e-04 | 200 | 38 | 4 | M3355 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 1.98e-04 | 200 | 38 | 4 | M8497 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP | 1.98e-04 | 200 | 38 | 4 | M9649 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 2.74e-04 | 402 | 38 | 5 | M5275 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-07 | 182 | 38 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-07 | 184 | 38 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-07 | 185 | 38 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.18e-07 | 199 | 38 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.87e-05 | 186 | 38 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 189 | 38 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.03e-05 | 190 | 38 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.08e-05 | 191 | 38 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.08e-05 | 191 | 38 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.12e-05 | 192 | 38 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.12e-05 | 192 | 38 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-05 | 193 | 38 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.16e-05 | 193 | 38 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.21e-05 | 194 | 38 | 4 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.25e-05 | 195 | 38 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.25e-05 | 195 | 38 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.25e-05 | 195 | 38 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.25e-05 | 195 | 38 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 195 | 38 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.30e-05 | 196 | 38 | 4 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | critical|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.44e-05 | 199 | 38 | 4 | 16c55cb8a0e740342009965f0eddfb0ed2858fab | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 137 | 38 | 3 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.98e-04 | 153 | 38 | 3 | 7518187a5fbf6c0881182dc79bd37c2d49f92b2e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-04 | 153 | 38 | 3 | 93d36723f01c2df39feebf20f3eba5b4fb4cdf59 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.16e-04 | 156 | 38 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.65e-04 | 164 | 38 | 3 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 3.85e-04 | 167 | 38 | 3 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.99e-04 | 169 | 38 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-04 | 169 | 38 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-04 | 169 | 38 | 3 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.13e-04 | 171 | 38 | 3 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.13e-04 | 171 | 38 | 3 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.20e-04 | 172 | 38 | 3 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-04 | 173 | 38 | 3 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.34e-04 | 174 | 38 | 3 | f1510b0f7771936adf29ae3572feab55db31832b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.34e-04 | 174 | 38 | 3 | 5d5d2fc60afff47f997751e8e9ca1367a22d19ec | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-04 | 175 | 38 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.49e-04 | 176 | 38 | 3 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-04 | 177 | 38 | 3 | aef050784abbba45c4ab4e8328339c8739c5c453 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.56e-04 | 177 | 38 | 3 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 178 | 38 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.72e-04 | 179 | 38 | 3 | fad1fbee002fcd424c03460d695559060ce41a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.72e-04 | 179 | 38 | 3 | 6d4e4b64e633b2ae8514ffa1e45829d6508dac54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.72e-04 | 179 | 38 | 3 | 61a7cc01fae4115325fce0efaa5bacf8f9af5ba2 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-04 | 179 | 38 | 3 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 4.72e-04 | 179 | 38 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.95e-04 | 182 | 38 | 3 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.95e-04 | 182 | 38 | 3 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.95e-04 | 182 | 38 | 3 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-04 | 183 | 38 | 3 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-04 | 183 | 38 | 3 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.11e-04 | 184 | 38 | 3 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.19e-04 | 185 | 38 | 3 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.19e-04 | 185 | 38 | 3 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 186 | 38 | 3 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.27e-04 | 186 | 38 | 3 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-04 | 186 | 38 | 3 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.36e-04 | 187 | 38 | 3 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.36e-04 | 187 | 38 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-04 | 187 | 38 | 3 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-04 | 188 | 38 | 3 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.44e-04 | 188 | 38 | 3 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | control-Myeloid-Neutrophils_4|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.44e-04 | 188 | 38 | 3 | 22d76c222fb0e3da08e10191af0090f14e03f2ad | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 5.44e-04 | 188 | 38 | 3 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.44e-04 | 188 | 38 | 3 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 5.44e-04 | 188 | 38 | 3 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.44e-04 | 188 | 38 | 3 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-04 | 189 | 38 | 3 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 5.52e-04 | 189 | 38 | 3 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 189 | 38 | 3 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.52e-04 | 189 | 38 | 3 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.52e-04 | 189 | 38 | 3 | 57ab947b81dbd9d3e896be89e28c4a62cf720837 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.52e-04 | 189 | 38 | 3 | ebc16b8eab84167d74446783d7e802acedc6b9c6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-04 | 189 | 38 | 3 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 5.52e-04 | 189 | 38 | 3 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.52e-04 | 189 | 38 | 3 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 189 | 38 | 3 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 190 | 38 | 3 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-04 | 190 | 38 | 3 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-04 | 190 | 38 | 3 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 190 | 38 | 3 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-04 | 190 | 38 | 3 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-04 | 191 | 38 | 3 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 191 | 38 | 3 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 191 | 38 | 3 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 191 | 38 | 3 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 191 | 38 | 3 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 5.69e-04 | 191 | 38 | 3 | a862a571625ab7238589ff201e5954f602c3bd7e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.69e-04 | 191 | 38 | 3 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.78e-04 | 192 | 38 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 5.78e-04 | 192 | 38 | 3 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.78e-04 | 192 | 38 | 3 | 6c269d2426f76559d2ed3bf2169eb4be5fc7ad6d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-04 | 192 | 38 | 3 | 348d39da3016dc6dbfa65d108e5def35aa7f19dd | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 5.78e-04 | 192 | 38 | 3 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.78e-04 | 192 | 38 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.87e-04 | 193 | 38 | 3 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-04 | 193 | 38 | 3 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| Drug | stanolone benzoate | 8.13e-06 | 3 | 38 | 2 | ctd:C040109 | |
| Drug | glutamin | 9.77e-06 | 461 | 38 | 7 | CID000000738 | |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A | 1.46e-05 | 188 | 38 | 5 | 2161_DN | |
| Drug | perfluoroundecanoic acid | 1.62e-05 | 4 | 38 | 2 | CID000077221 | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | 1.70e-05 | 194 | 38 | 5 | 1310_DN | |
| Drug | TCPOBOP | 1.88e-05 | 95 | 38 | 4 | CID000005382 | |
| Drug | butamben | 4.05e-05 | 6 | 38 | 2 | ctd:C004605 | |
| Drug | 1-(2-chloroethyl)-1-nitrosourea | 4.71e-05 | 42 | 38 | 3 | CID000075394 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 7.87e-09 | 4 | 38 | 3 | DOID:0060038 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 4.84e-06 | 3 | 38 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.14e-05 | 447 | 38 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | prostate cancer (is_marker_for) | 4.82e-05 | 156 | 38 | 4 | DOID:10283 (is_marker_for) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 1.06e-04 | 12 | 38 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | Crohn's disease | 2.44e-04 | 441 | 38 | 5 | EFO_0000384 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 2.72e-04 | 19 | 38 | 2 | EFO_0000220, GO_0097327 | |
| Disease | cumulative dose response to bevacizumab | 2.72e-04 | 19 | 38 | 2 | EFO_0005944 | |
| Disease | Adenoid Cystic Carcinoma | 2.92e-04 | 100 | 38 | 3 | C0010606 | |
| Disease | Malignant neoplasm of breast | 3.90e-04 | 1074 | 38 | 7 | C0006142 | |
| Disease | childhood trauma measurement | 4.38e-04 | 24 | 38 | 2 | EFO_0007979 | |
| Disease | Cerebral Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C0334583 | |
| Disease | Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 4.75e-04 | 25 | 38 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 4.75e-04 | 25 | 38 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 5.15e-04 | 26 | 38 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 5.15e-04 | 26 | 38 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 5.15e-04 | 26 | 38 | 2 | C0334582 | |
| Disease | Mammary Carcinoma, Human | 5.41e-04 | 525 | 38 | 5 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.41e-04 | 525 | 38 | 5 | C1257931 | |
| Disease | Mammary Neoplasms | 5.50e-04 | 527 | 38 | 5 | C1458155 | |
| Disease | Anaplastic astrocytoma | 5.55e-04 | 27 | 38 | 2 | C0334579 | |
| Disease | Breast Carcinoma | 6.04e-04 | 538 | 38 | 5 | C0678222 | |
| Disease | selenium measurement | 6.41e-04 | 29 | 38 | 2 | EFO_0006331 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 6.87e-04 | 30 | 38 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | 7.77e-04 | 1206 | 38 | 7 | EFO_0004458 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.64e-04 | 145 | 38 | 3 | DOID:1289 (implicated_via_orthology) | |
| Disease | alcohol consumption measurement | 9.24e-04 | 1242 | 38 | 7 | EFO_0007878 | |
| Disease | neuroticism measurement | 9.99e-04 | 909 | 38 | 6 | EFO_0007660 | |
| Disease | Carcinoma, Transitional Cell | 1.28e-03 | 41 | 38 | 2 | C0007138 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.41e-03 | 43 | 38 | 2 | DOID:9074 (implicated_via_orthology) | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1.90e-03 | 50 | 38 | 2 | C1862939 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.36e-03 | 206 | 38 | 3 | C0152013 | |
| Disease | insomnia measurement | 2.47e-03 | 443 | 38 | 4 | EFO_0007876 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NMLPNAAGMVPVSMN | 656 | Q09472 | |
| SQPGMDVNQMSFNPM | 151 | Q8NDM7 | |
| MTMETQMSQNVCPRN | 1 | P12318 | |
| VSLPPASVAMAMNQM | 326 | Q96NX9 | |
| TSQNVSKRPMQQMQP | 686 | Q96EV2 | |
| SMQPANMMGPLTQQM | 326 | Q6XE24 | |
| TMRDQRAMMIQTPSQ | 886 | P29074 | |
| QNRMMAIAPNVTVMV | 276 | Q9Y2X3 | |
| QQCAMAPPTMMPSVQ | 3271 | Q8NEZ4 | |
| NMQQPMNVMTQSFGA | 511 | Q14677 | |
| PQSMMVPNRNSHNME | 406 | O95835 | |
| MMQTLQGPTNVEDMN | 431 | Q9UI26 | |
| VAMMTPQVITPQQMQ | 91 | O15409 | |
| MMTPQVITPQQMQQI | 101 | Q9H334 | |
| AMMSPQMLTPQQMQQ | 106 | Q8IVH2 | |
| TPAVQMRPMNQMSQT | 1021 | Q8IZL2 | |
| MRPMNQMSQTLNGQT | 1026 | Q8IZL2 | |
| SRAQLMPQGQMMVNP | 651 | Q14686 | |
| QMMPDVSIQQTNMVP | 816 | Q14686 | |
| QRMPMQQSGSVPVMV | 1066 | Q14686 | |
| PNTITMIPNTLMGMQ | 776 | Q8NFZ3 | |
| SIDQQMIQSQRPMML | 626 | Q8NCM8 | |
| MSPPQGLMTQQNFML | 1421 | Q86UU0 | |
| PTVNPMSTAMQNERN | 516 | Q13873 | |
| PRPLTNMNDTMVSHM | 336 | O60941 | |
| MMQRRMSQENPSQAT | 2621 | Q99698 | |
| MIYCQRMSPPQQEMT | 111 | Q5JT82 | |
| SQLPINMMQPQMNVM | 1201 | Q99590 | |
| QQQGFPMVSVMQPNM | 46 | Q9UMZ2 | |
| MSMSPNQGLQMPSSR | 401 | Q9Y6Q9 | |
| MRPMMQPQVSSQQGF | 1206 | Q9Y6Q9 | |
| ETSMPMTMVFQNQVV | 861 | Q6ZUM4 | |
| MDTSNNMIPQIMPSI | 241 | Q99717 | |
| ILPMNPRNMMNHSQV | 131 | Q9NZN8 | |
| RTNINMQSNPVSMMQ | 176 | O75177 | |
| MQSNPVSMMQQQAAT | 181 | O75177 | |
| MSPRMAHTQSPMMQQ | 1326 | Q15596 | |
| TPQMPTQAMFMAPAQ | 276 | Q8WU79 | |
| MNMPVNKSPMINTCG | 1 | C9JQI7 | |
| QSMPVQNQMTMSQGQ | 171 | Q15532 | |
| IMQQHPEMIQQMLST | 971 | Q9UIA9 | |
| MSNPRAMQALMQIQQ | 446 | Q9UHD9 | |
| QRQLMSNPEMLSQIM | 186 | Q9NRR5 |